Vancouver richmond early psychosis intervention program

Fred J. Author information Article notes Copyright and License information Disclaimer. This article was submitted to Schizophrenia, a section of the journal Frontiers in Psychiatry. Received May 2; Accepted Aug 4. The use, distribution or reproduction in other forums is permitted, provided the original author s or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice.

No use, distribution or reproduction is permitted which does not comply with these terms. This article has been cited by other articles in PMC. Abstract Psychotic disorders most commonly appear during the late teenage years and early adulthood. Keywords: psychosis, antipsychotic, metabolic syndrome and diabetes mellitus, exercise, health coaching, mental illness, schizophrenia.

Introduction The age of onset of schizophrenia spectrum disorders and most other forms of idiopathic psychosis is typically during the later teenage years through the early- to mids. The services that are available at the program include individualized care in the following areas: Assessment Treatment Medication management Second opinions Consultations Case management Support and recovery Prevention of relapse Support returning to work or school Assistance to families to manage their family life in relation to their family member Patient and family psychoeducation.

Cardiometabolic health in patients treated with antipsychotic drugs It is now well known that individuals with a psychotic disorder who are treated with an antipsychotic drug are significantly more likely to exhibit poor metabolic and cardiovascular health compared to the general population When initially setting goals, patients are encouraged to think a goal through, with regard to the following questions: What skills do I need to achieve this?

What information or knowledge do I need? What help, assistance, or collaboration do I need? What resources do I need? What can block my progress? Am I making any assumptions? Is there a better way of doing things? Is health coaching effective for improving metabolic health in people with psychotic disorders?

Hypothesis Based on the proven value of Integrative Health Coaching Programs in improving the long-term health of patient populations with regard to obesity, type 2 DM, and cardiovascular risk, we are testing the following hypothesis: in a first-episode psychosis population that has recently begun treatment with atypical antipsychotic drugs, the inclusion of an Integrative Health Coaching goal-setting model will significantly improve metabolic health outcomes compared to usual treatment.

Outcome measures We use routine measures of metabolic health, which are used for all patients who enter the EPI program. Protocol Design: The study is a longitudinal, naturalistic intake study. Open in a separate window. Figure 1. Anticipated significance The present study will be the first ever to use MRI to assess the effects of atypical antipsychotic drugs on levels of visceral and subcutaneous fat, as well as lipid infiltration of the liver, in patients recently starting antipsychotic drugs.

Hypothesis Genetic variants will be identified that predict metabolic responses to antipsychotic drugs. Significance Based on the highly detailed metabolic phenotype we will measure, we anticipate that the genomic findings from the current proposal will provide important novel targets to help us understand the metabolic side effects of antipsychotic drugs, either in terms of predicting which drugs may be better or worse for specific individuals, or indicating potential physiological pathways to study for future drug development.

Concluding Remarks The beneficial effects of EPI programs on mental health and functional outcome are now well established in patients with a psychotic disorder. Conflict of Interest Statement Dr. Acknowledgments We would like to thank Dr. References 1. The prodrome and clinical risk for psychotic disorders.

First-episode schizophrenia: I. Early course parameters. Schizophr Bull 22 — Psychiatr Serv 60 — Early detection and intervention with schizophrenia: rationale. How successful are first episode programs? A review of the evidence for specialized assertive early intervention. Curr Opin Psychiatry 27 — Birchwood M. Early intervention and sustaining the management of vulnerability. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.

Arch Gen Psychiatry 62 — Benefits of enriched intervention compared with standard care for patients with recent-onset psychosis: a metaanalytic approach. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 65 — Symptom and functional outcomes for a 5 year early intervention program for psychoses.

Schizophr Res — Raedler TJ. Cardiovascular aspects of antipsychotics. Curr Opin Psychiatry 23 — Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med 41 — Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Life expectancy and cardiovascular mortality in persons with schizophrenia.

Curr Opin Psychiatry 25 — Predictors of starting to smoke cigarettes in patients with first episode psychosis. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacol Ther — Preclinical models of antipsychotic drug-induced metabolic side effects.

Trends Pharmacol Sci 31 — Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats. Vascul Pharmacol Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility. J Clin Psychopharmacol 34 — Curr Psychiatry Rep 15 Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in Canadian outpatients.

J Clin Psychiatry 71 — Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. CNS Drugs 21 — Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27 — Arterioscler Thromb Vasc Biol 24 :e13— American Heart Association. Metabolic syndrome: new guidance for prevention and treatment. Prediabetes in patients treated with antipsychotic drugs. J Clin Psychiatry 73 — Prevalence of the metabolic syndrome in veterans with schizophrenia.

J Psychiatr Pract 12 :5— Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context. Australas Psychiatry 18 — Schizophr Res 80 — Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. Eur Child Adolesc Psychiatry 22 — Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

J Child Adolesc Psychopharmacol 21 — Clin Rehabil 23 — Marshall M, Rathbone J. Early intervention for psychosis. Psychiatr Serv 64 — Management of physical health in patients with schizophrenia: practical recommendations. Eur Psychiatry 25 Suppl 2 :S41— Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension. Int Clin Psychopharmacol 29 — Management of medication-related cardiometabolic risk in patients with severe mental illness. Curr Cardiovasc Risk Rep 7 — Metabolic side effects of antipsychotic drug treatment — pharmacological mechanisms.

Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.

PLoS One 8 :e Antipsychotic polypharmacy increases metabolic dysregulation in female rats. Exp Clin Psychopharmacol 21 — Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats. Neuroscience — Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats.

Neuropharmacology 62 — A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model. Prog Neuropsychopharmacol Biol Psychiatry 34 — Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 48 — Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats. Int J Neuropsychopharmacol 17 — Irwin explained that the target group is generally independent, and not always being looked after by their parents or a partner.

Stress does not cause these conditions but it can mask their existence, said Irwin. Christina Yee, a third-year political science student who is putting up posters on campus for the campaign, feels that psychosis is a serious issue for people in university. The EPI program has set up a website, www. Those with questions regarding psychosis, or who know someone who needs help or referral to these programs, can call the EPI help line at Post a Comment. Rehabilitation readiness assessment exploration of service options, building confidence.

Rehabilitation processes assistance with goal achievement. Our Geriatric psychiatry outreach team provides comprehensive geriatric psychiatry assessment and treatment. Our program is intended for patients greater than 65 years old and suffering from dementia, delirium, disruptive behaviour, incontinence, failure to thrive as well as those with increased risks of institutionalization.

Some of the services we provide are:. Youth living in Richmond and Vancouver, aged 30, are eligible for our program. We also work with families of people who are experiencing psychotic symptoms for the first time. VISU provides intensive supervision and services to clients with mental illnesses serving adult provincial sentences in the community.

Assistance with treatment, housing, living skills, financial management and health care is provided in addition to supervision of court orders. Our Assertive Community Treatment ACT team provide community treatment and rehabilitation for clients struggling with mental illness who may also have severe substance use addictions.